Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Shares, par value (euro)0.12 per share
-
Shares outstanding
-
22.4M
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
14.1M
-
Shares change
-
+3.67M
-
Total reported value, excl. options
-
$1.28B
-
Value change
-
+$338M
-
Put/Call ratio
-
1.29
-
Number of buys
-
61
-
Number of sells
-
-18
-
Price
-
$91.46
Significant Holders of CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) as of Q1 2021
114 filings reported holding CVAC - CureVac N.V. - Common Shares, par value (euro)0.12 per share as of Q1 2021.
CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.1M shares
of 22.4M outstanding shares and own 62.68% of the company stock.
Largest 10 shareholders include BAILLIE GIFFORD & CO (5.83M shares), Bill & Melinda Gates Foundation (3.13M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.37M shares), NORGES BANK (491K shares), DEUTSCHE BANK AG\ (478K shares), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main (372K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (316K shares), CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (218K shares), CAAS CAPITAL MANAGEMENT LP (143K shares), and GEODE CAPITAL MANAGEMENT, LLC (139K shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.